The role of PGRMC1 in hepatic cholesterol homeostasis
The role of PGRMC1 in hepatic cholesterol homeostasis
批准号:
8210363
负责人:
Rita Thomas Brookheart
金额:
$5.22万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-01-01 至 2013-12-31
关键词:
AdultAffectBile AcidsBindingCardiovascular DiseasesCellsCellular MembraneCholesterolCholesterol HomeostasisCytochrome P450DevelopmentDietary intakeEmbryoEnzymesExcretory functionHemeHepaticHumanHydroxymethylglutaryl-CoA reductaseInvestigationKidneyKnowledgeLanosterolLeadLipidsLipoproteinsLiverMembrane ProteinsMetabolismMixed Function OxygenasesOrganPharmaceutical PreparationsPrevalencePreventiveRoleSerumSignal TransductionSteroidsStructureTestingTherapeuticbasecardiovascular disorder riskfluidityheme-binding proteinnovelnovel strategiesnovel therapeutic interventionparticlepreventpublic health relevancesmall hairpin RNAsterol homeostasis
中文摘要
性状(由申请方提供):胆固醇对细胞膜的适当结构和流动性以及膜蛋白的功能至关重要。胆固醇也是类固醇、氧化固醇和胆汁酸的前体。这些代谢物在信号转导中起重要作用,并且在胆汁酸的情况下,起脂质增溶作用。血清胆固醇水平升高与心血管疾病(CVD)风险增加有关。清楚地了解细胞如何调节胆固醇合成将加速开发新的预防和治疗CVD的方法。在人类中,胆固醇在体内的供应受几个因素控制,包括饮食摄入,合成,储存和排泄。胆固醇合成和代谢的关键调节剂是细胞色素P450单加氧酶。从羊毛甾醇合成胆固醇需要P450酶Cyp51A1。我们的实验室最近鉴定了血红素结合蛋白PGRMC1作为Cyp51A1的结合伴侣和正调节因子,并证明了人胚肾(HEK)293细胞中PGRMC1的shRNA敲低会破坏胆固醇合成。PGRMC1和Cyp51A1都在肝脏中高度表达,肝脏是胆固醇代谢的重要器官。基于这些发现,我假设PGRMC 1是肝脏胆固醇合成的关键调节因子,并且是维持全身胆固醇稳态所必需的。我的目标是:(1)确定PGRMC 1在肝胆固醇合成中的功能和(2)研究PGRMC 1在系统性固醇稳态中的作用。总之,这些研究将有助于阐明PGRMC 1在胆固醇稳态中的功能。
公共卫生相关性:血清胆固醇水平高的成年人患心血管疾病的风险增加。该项目将确定新型细胞色素P450调节剂PGRMC 1在肝脏和全身胆固醇稳态中的功能。对PGRMC 1功能的清楚理解将增加我们对胆固醇稳态如何实现的知识,并可能揭示降低血清胆固醇水平和降低心血管疾病患病率的新治疗方法。
英文摘要
DESCRIPTION (provided by applicant): Cholesterol is essential for the proper structure and fluidity of cellular membranes and for the function of membrane proteins. Cholesterol also serves as a precursor of steroids, oxysterols, and bile acids. These metabolites serve important functions in signal transduction and, in the case of bile acids, lipid solubilization. Elevated serum cholesterol levels are associated with increased risk for cardiovascular disease (CVD). A clear understanding of how cells regulate cholesterol synthesis will accelerate the development of novel preventive and therapeutic approaches to CVD. In humans, the supply of cholesterol in the body is controlled by several factors including dietary intake, synthesis, storage, and excretion. Key regulators of cholesterol synthesis and metabolism are the cytochrome P450 monooxygenases. The synthesis of cholesterol from lanosterol requires the P450 enzyme, Cyp51A1. Our lab recently identified the heme-binding protein PGRMC1 as a binding partner and positive regulator of Cyp51A1 and demonstrated that shRNA knockdown of PGRMC1 in human embryonic kidney (HEK) 293 cells disrupts cholesterol synthesis. PGRMC1 and Cyp51A1 are both highly expressed in the liver-an essential organ in cholesterol metabolism. Based on these findings, I hypothesize that PGRMC1 is a critical regulator of hepatic cholesterol synthesis and is necessary for maintaining systemic cholesterol homeostasis. My aims are to: (1) Determine the function of PGRMC1 in hepatic cholesterol synthesis and (2) Investigate the role of PGRMC1 in systemic sterol homeostasis. Together, these investigations will help elucidate the function of PGRMC1 in cholesterol homeostasis.
PUBLIC HEALTH RELEVANCE: Adults with high serum cholesterol levels have an increased risk of cardiovascular disease. This project will determine the function of the novel cytochrome P450 regulator PGRMC1 in hepatic and systemic cholesterol homeostasis. A clear understanding of PGRMC1 function will increase our knowledge of how cholesterol homeostasis is achieved and may reveal new therapeutic approaches for lowering serum cholesterol levels and reducing the prevalence of cardiovascular disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
-
批准号:10421052
-
项目类别:
-
资助金额:$12.08万
-
财政年份:2019
-
负责人:Rita Thomas Brookheart
-
依托单位:
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
-
批准号:10186796
-
项目类别:
-
资助金额:$12.08万
-
财政年份:2019
-
负责人:Rita Thomas Brookheart
-
依托单位:
Site-1 Protease in the regulation of skeletal muscle metabolism and exercise endurance
-
批准号:10630296
-
项目类别:
-
资助金额:$6.74万
-
财政年份:2019
-
负责人:Rita Thomas Brookheart
-
依托单位:
The role of PGRMC1 in hepatic cholesterol homeostasis
-
批准号:8402604
-
项目类别:
-
资助金额:$5.39万
-
财政年份:2011
-
负责人:Rita Thomas Brookheart
-
依托单位:
The role of PGRMC1 in hepatic cholesterol homeostasis
-
批准号:8060758
-
项目类别:
-
资助金额:$4.84万
-
财政年份:2011
-
负责人:Rita Thomas Brookheart
-
依托单位:
Regulation of Lipotoxicity by the non-coding RNA gadd7
-
批准号:7231127
-
项目类别:
-
资助金额:$2.68万
-
财政年份:2006
-
负责人:Rita Thomas Brookheart
-
依托单位:
Regulation of Lipotoxicity by the non-coding RNA gadd7
-
批准号:7294862
-
项目类别:
-
资助金额:$2.16万
-
财政年份:2006
-
负责人:Rita Thomas Brookheart
-
依托单位:
海外基金